内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2021 KDA临床实践指南：糖尿病

2021-07-15 韩国糖尿病协会 Diabetes Metab J

糖尿病

2021年7月，韩国糖尿病协会(KDA)发布了韩国第7版糖尿病指南，主要对糖尿病的筛查和降糖药物的应用建议进行修订，增加了连续血糖监测、胰岛素泵的应用以及糖尿病患者非酒精性脂肪性肝病章节。

中文标题：

2021 KDA临床实践指南：糖尿病

英文标题：

2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

发布机构：

韩国糖尿病协会

发布日期：

2021-07-15

简要介绍：

2021年7月，韩国糖尿病协会(KDA)发布了韩国第7版糖尿病指南，主要对糖尿病的筛查和降糖药物的应用建议进行修订，增加了连续血糖监测、胰岛素泵的应用以及糖尿病患者非酒精性脂肪性肝病章节。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 KDA临床实践指南：糖尿病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=582de1c002213276, title=2021 KDA临床实践指南：糖尿病, enTitle=2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association, guiderFrom=Diabetes Metab J, authorId=0, author=, summary=2021年7月，韩国糖尿病协会(KDA)发布了韩国第7版糖尿病指南，主要对糖尿病的筛查和降糖药物的应用建议进行修订，增加了连续血糖监测、胰岛素泵的应用以及糖尿病患者非酒精性脂肪性肝病章节。, cover=https://img.medsci.cn/20211018/1634530190066_5295905.jpg, journalId=0, articlesId=null, associationId=1536, associationName=韩国糖尿病协会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jul 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年7月，韩国糖尿病协会(KDA)发布了韩国第7版糖尿病指南，主要对糖尿病的筛查和降糖药物的应用建议进行修订，增加了连续血糖监测、胰岛素泵的应用以及糖尿病患者非酒精性脂肪性肝病章节。</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=52991, appHits=421, showAppHits=0, pcHits=1374, showPcHits=52569, likes=0, shares=24, comments=4, approvalStatus=1, publishedTime=Mon Oct 18 21:05:33 CST 2021, publishedTimeString=2021-07-15, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Oct 18 20:41:01 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 18:35:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 KDA临床实践指南：糖尿病.pdf)])
2021 KDA临床实践指南：糖尿病.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1085030, encodeId=f0b51085030a0, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Tue Dec 28 09:49:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070829, encodeId=0dc510e082963, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aef35692080, createdName=ms7000001007691742, createdTime=Tue Nov 16 17:47:49 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067689, encodeId=95ce106e6891f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Sat Nov 06 23:16:38 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-28 278103059

    学习！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1085030, encodeId=f0b51085030a0, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Tue Dec 28 09:49:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070829, encodeId=0dc510e082963, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aef35692080, createdName=ms7000001007691742, createdTime=Tue Nov 16 17:47:49 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067689, encodeId=95ce106e6891f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Sat Nov 06 23:16:38 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-16 ms7000001007691742

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1085030, encodeId=f0b51085030a0, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Tue Dec 28 09:49:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070829, encodeId=0dc510e082963, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aef35692080, createdName=ms7000001007691742, createdTime=Tue Nov 16 17:47:49 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067689, encodeId=95ce106e6891f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Sat Nov 06 23:16:38 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-06 121bb8d4m13暂无昵称

    学习

    0

相关指南

2021 国际专家共识建议：临床实践中糖尿病感觉运动多神经病的筛查，诊断和管理

国外内分泌相关专家小组（统称） · 2021-09-18

中国老年糖尿病诊疗指南(2021年版)

中华医学会老年医学分会 · 2021-01-29

糖尿病合并高脂血症病证结合诊疗指南

中国医师协会中西医结合医师分会(DSIM/CMDA,Doctor Society of integrative Medicine，Chinese Medical Doctor Association) · 2021-07-19

2021 老年2型糖尿病管理专家共识——糖尿病和衰弱

国外内分泌相关专家小组（统称） · 2021-05-12

中国养老机构居民血糖标准管理临床专家共识（2021版）

中国老年协会内分泌代谢病学组 · 2021-07-07

基层糖尿病微血管病变筛查与防治专家共识（2021年版）

中国微循环学会(CMS,Chinese Society of Microcirculation) 糖尿病与微循环专业委员会 · 2021-06-17

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01